PAS
CABA icon

Point72 Asia (Singapore)’s Cabaletta Bio CABA Stock Holding History

Point72 Asia (Singapore)’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$20.9K Sell
8,935
-25,832
-74% -$44.3K ﹤0.01% 708
2025
Q2 		$52.8K Buy
+34,767
New +$54.2K 0.01% 580
2024
Q4 		– Sell
-6,680
Closed -$31.5K – 894
2024
Q3 		$31.5K Buy
+6,680
New +$38.7K 0.01% 755

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return

Point72 Asia (Singapore)'s CABA Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Cabaletta Bio (CABA) stake by 74% in Q3 2025, selling an estimated $44.3K and leaving 8,935 shares worth $20.9K. The position accounts for ﹤0.01% of the portfolio, ranked #708.

Point72 Asia (Singapore) first reported a position in CABA in Q3 2024 and has held it in 3 quarters since. The position peaked at $52.8K in Q2 2025. 75 funds tracked by Wall St. Rank hold CABA as of Q3 2025.

  • Point72 Asia (Singapore) held 8,935 shares of Cabaletta Bio worth $20.9K as of Q3 2025.
  • Point72 Asia (Singapore) sold 25,832 Cabaletta Bio shares in Q3 2025, an estimated $44.3K.
  • Cabaletta Bio made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #708 holding.
  • Point72 Asia (Singapore) first reported a position in Cabaletta Bio in Q3 2024 and has held it in 3 quarters since.
  • Point72 Asia (Singapore)'s Cabaletta Bio position peaked at $52.8K in Q2 2025.
  • 75 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.